WEE1 and small cell lung carcinoma: Thus, there may be a nonclassical pathway of Wee1 that does not lead to drug resistance in SCLC through cell cycle checkpoints, but whether this type of mechanism of action is real and even whether it can serve as a target for antagonizing drug resistance in SCLC are key questions that need to be addressed.